MARY BRISCOE: Open Payments
NPI 1285642926 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,373 in 66 payments from 14 companies in 2025. Trend: 2023 $959 · 2024 $1,357 · 2025 $1,373
Food & beverage: $1,363Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $424 |
| ABBVIE INC. | 14 | $255 |
| Ardelyx, Inc. | 7 | $116 |
| QOL Medical, LLC | 4 | $97 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
| Ipsen Biopharmaceuticals, Inc | 2 | $85 |
| Phathom Pharmaceuticals, Inc. | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Aimmune Therapeutics, Inc. | 3 | $46 |
| GENZYME CORPORATION | 2 | $37 |
Products named: TREMFYA, LINZESS, DUPIXENT, IBSRELA, Sucraid, IQIRVO, VOQUEZNA, ENTYVIO.
Industry payments across LA — which companies pay providers there.
